Very interesting times ahead for GAPNews schedule looks like April, May, and June on the forecast.
April should be initial test results from Ottawa on animal models of Ovarian cancer.
May should be initial test results from Kingston on in vitro testing on Bladder cancer.
June should be news on the design prototype formulations from Northern Lipids that should carry us forward into Human Trials down the road.
Looks like the spec buying is lined up for the first news release... spikes last week were too obvious.
This should go up and down like a yo yo. Good money to be made here.